Get CEO.CA Pro
Real-time Level 2 Market Depth
Click for live demo
back
featured articles
May 15, 2024
PharmaDrug's Sairiyo Therapeutics Submits Clinical Trial Application for Phase 1 Study of Patented Reformulated Cepharanthine $LMLLF.US $PHRX $G11 $CA71716W1059
PharmaDrug's Sairiyo Therapeutics Submits Clinical Trial Application for Phase 1 Study of Patented Reformulated Cepharanthine $LMLLF.US $PHRX $G11 $CA71716W1059
May 14, 2024
Western Alaska Minerals Announces Closing of Second and Final Tranche of Upsized Non-Brokered Private Placement $WAM
Western Alaska Minerals Announces Closing of Second and Final Tranche of Upsized Non-Brokered Private Placement $WAM
May 13, 2024
Nicola Mining Announces Commencement of 3D IP Survey at New Craigmont Copper Project $HUSIF.US $NIM $HLIA $CA65405R2037
Nicola Mining Announces Commencement of 3D IP Survey at New Craigmont Copper Project $HUSIF.US $NIM $HLIA $CA65405R2037
May 13, 2024
Canada Nickel Achieves Initial Metallurgical Success at Mann Northwest Property $CNIKF.US $CNC
Canada Nickel Achieves Initial Metallurgical Success at Mann Northwest Property $CNIKF.US $CNC
show more ▾
CEO.CA Chairman's Briefing
Global Markets. Mining Trends. Every Thursday.
read first
Please read the CEO.CA House Rules before posting.
social
legal
Use of this site indicates acceptance of the
Privacy Policy
and
Terms of Use.
The information on this Website is not reliable and not intended to provide tax, legal, or investment advice. Nothing contained on the Website shall be considered a recommendation, solicitation, or offer to buy or sell a security to any person in any jurisdiction.
CEO.CA members discuss high-risk penny stocks which can lose their entire value. Only risk what you can afford to lose.
© 2022 - CEO.CA Technologies Ltd.
#catching-up-with-keir-reynolds/terms-of-use
#catching-up-with-keir-reynolds/terms-of-use ↻
0 online
Today
This week
Search
Subscribe
No more messages to load
Sign up to become a contributing member of the community.
Trending
Personal channels
